Duration of the project
06.09.2024. - 31.10.2024.
Countries and institutions involved in the project
Lithuanian University of Health Sciences
University of Regensburg
Project manager
Robertas Pranevičius
Short description of the achieved project aim(s)
New methods for studying the impact of the chromatin remodeling protein SMARCAD1 on HERV (Human Endogenous Retrovirus) expression were acquired. A seminar was held at LSMU on October 14, 2024, to discuss the methods acquired in Germany.
Direct and indirect target group of the project
Direct: 22
Indirect: 45
